SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sam who wrote (5288)9/11/1998 10:57:00 AM
From: Steve Fancy  Read Replies (1) of 6136
 
Well, I think a close again tonight above 28 could be considered a breakout. Without looking at a chart, I would guess AGPH would encounter resistance at 28, 30 and a truckload of wood to chop at 33-34. Based on the continued strength still doesn't seem like time to sell calls. My concern is that one of these days we wake up and it's back down to 25. Also concerned about the upcoming trade shows in that AGPH doesn't weather these well. Maybe we'll get some news this time. It seems to me the driving force of the last week or so is something other than short covering, with the shorts magnifying the upside as Peter suggested. Maybe just strength in the biotechs in general, but my observations suggest AGPH has been much stronger than most, and has maintained gains on otherwise stagnant days for the rest of the sector. In that IMNR is doggin it, I suspect this isn't Remune related which might otherwise have been my first guess.

sf

sf
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext